Ceramide Risk Score in the Evaluation of Metabolic Syndrome: An Additional or Substitutive Biochemical Marker in the Clinical Practice?

Ceramide Risk Score in the Evaluation of Metabolic Syndrome: An Additional or Substitutive Biochemical Marker in the Clinical Practice?

Ceramide risk score (CERT1, ceramide test 1), based on specific ceramides (Cers) and their corresponding ratios in the plasma, has been reported as a promising biochemical marker for primary and secondary prediction of cardiovascular disease (CVD) risk in different populations of patients. Thus far,...

Full description

Bibliographic Details
Main Authors: Antonello E. Rigamonti, Michele Dei Cas, Diana Caroli, Adele Bondesan, Silvano G. Cella, Rita Paroni, Alessandro Sartorio
Format: Article
Language:English
Published: MDPI AG 2023-08-01
Series:International Journal of Molecular Sciences
Subjects:
metabolic syndrome
obesity
ceranides
CERT1
cardiovascular disease risk
Online Access:https://www.mdpi.com/1422-0067/24/15/12452

Internet

https://www.mdpi.com/1422-0067/24/15/12452

Similar Items